Table of contents

  • Preliminary pages
  • Title & verso title
  • Contents
  • Acknowledgments
  • Abbreviations
  • Symbols
  • Summary
    • Overall health impact of overweight and obesity
    • Overweight and obesity burden greatest in lowest socioeconomic group
    • Little change in rates of overweight and obesity burden between 2003 and 2011
    • Around 14% of disease burden due to overweight and obesity could be avoided if the population’s body mass dropped slightly
  • Body content
    • 1 Introduction
      • 1.1 Structure of this report
    • 2 Methods
      • 2.1 Selected linked diseases and relative risks
      • 2.2 Determining overweight and obesity prevalence
      • 2.3 Theoretical minimum risk exposure distribution
      • 2.4 Quantifying overweight and obesity burden
      • 2.5 Socioeconomic group analysis
      • 2.6 Comparison with attributable burden in 2003
      • 2.7 Scenario modelling
    • 3 Burden due to overweight and obesity
      • 3.1 Total overweight and obesity burden
      • 3.2 Which diseases account for the most burden due to overweight and obesity?
        • Attributable burden by sex
      • 3.3 Was it due to fatal or non-fatal burden?
      • 3.4 How does the overweight and obesity burden vary by age?
        • Children aged 5–14
        • Adolescents aged 15–24
        • Adults aged 25–44
        • Adults aged 45–64
        • Adults aged 65–84
        • Adults aged 85+
      • 3.5 What proportion of burden for each linked disease is due to overweight and obesity?
        • Detailed estimates for selected linked diseases
        • Cardiovascular disease
        • Cancer
        • Diabetes
        • Musculoskeletal conditions
        • Chronic kidney disease
        • Dementia
    • 4 Variation across socioeconomic groups
    • 5 Changes between 2011 and 2003
    • 6 Scenario modelling
      • 6.1 Overweight and obesity prevalence in 2020
      • 6.2 Overweight /obesity burden comparison in 2020
      • 6.3 Scenario differences by age
    • 7 Discussion
      • 7.1 Key findings
      • 7.2 Potential for disease burden prevention
      • 7.3 Strengths, limitations and future directions
        • Strengths
        • Limitations
        • Using BMI as a measure of body mass
        • Quantifying future disease burden due to childhood obesity and cohort effects
        • Overweight and obesity prevalence and ABDS 2011 data
        • Complexities with scenario modelling
        • Future directions
      • 7.4 Conclusion
  • End matter
    • Appendix A: Detailed methods
      • Select linked diseases
      • Linked diseases not included in analysis
      • Determine population exposure: prevalence of overweight and obesity
      • Define the theoretical minimum risk exposure distribution
      • Calculate the population attributable fractions
      • Quantify the disease burden
      • Socioeconomic group analysis
      • Scenario modelling
      • Overweight and obesity prevalence in 2020
      • Linked disease burden in 2020
    • Appendix B: Selection of relative risks
      • Cancers
      • Cardiovascular diseases
      • Diabetes
      • Chronic kidney disease
      • Musculoskeletal conditions
      • Gallbladder disease
      • Dementia
      • Asthma
    • Appendix C: Additional tables
    • Glossary
    • References
    • List of tables
    • List of figures